Copyright Reports & Markets. All rights reserved.

Global Guillain-Barré Syndrome Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Guillain-Barré Syndrome Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Intravenous Immunoglobulin
      • 1.4.3 Plasma Exchange
      • 1.4.4 Analgesics
      • 1.4.5 Anticonvulsants
      • 1.4.6 LMWH
    • 1.5 Market by Application
      • 1.5.1 Global Guillain-Barré Syndrome Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Retail Pharmacies
      • 1.5.4 Home Care
      • 1.5.5 Clinics
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Guillain-Barré Syndrome Market Size
    • 2.2 Guillain-Barré Syndrome Growth Trends by Regions
      • 2.2.1 Guillain-Barré Syndrome Market Size by Regions (2014-2025)
      • 2.2.2 Guillain-Barré Syndrome Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Guillain-Barré Syndrome Market Size by Manufacturers
      • 3.1.1 Global Guillain-Barré Syndrome Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Guillain-Barré Syndrome Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Guillain-Barré Syndrome Market Concentration Ratio (CR5 and HHI)
    • 3.2 Guillain-Barré Syndrome Key Players Head office and Area Served
    • 3.3 Key Players Guillain-Barré Syndrome Product/Solution/Service
    • 3.4 Date of Enter into Guillain-Barré Syndrome Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Guillain-Barré Syndrome Market Size by Type (2014-2019)
    • 4.2 Global Guillain-Barré Syndrome Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Guillain-Barré Syndrome Market Size (2014-2019)
    • 5.2 Guillain-Barré Syndrome Key Players in United States
    • 5.3 United States Guillain-Barré Syndrome Market Size by Type
    • 5.4 United States Guillain-Barré Syndrome Market Size by Application

    6 Europe

    • 6.1 Europe Guillain-Barré Syndrome Market Size (2014-2019)
    • 6.2 Guillain-Barré Syndrome Key Players in Europe
    • 6.3 Europe Guillain-Barré Syndrome Market Size by Type
    • 6.4 Europe Guillain-Barré Syndrome Market Size by Application

    7 China

    • 7.1 China Guillain-Barré Syndrome Market Size (2014-2019)
    • 7.2 Guillain-Barré Syndrome Key Players in China
    • 7.3 China Guillain-Barré Syndrome Market Size by Type
    • 7.4 China Guillain-Barré Syndrome Market Size by Application

    8 Japan

    • 8.1 Japan Guillain-Barré Syndrome Market Size (2014-2019)
    • 8.2 Guillain-Barré Syndrome Key Players in Japan
    • 8.3 Japan Guillain-Barré Syndrome Market Size by Type
    • 8.4 Japan Guillain-Barré Syndrome Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Guillain-Barré Syndrome Market Size (2014-2019)
    • 9.2 Guillain-Barré Syndrome Key Players in Southeast Asia
    • 9.3 Southeast Asia Guillain-Barré Syndrome Market Size by Type
    • 9.4 Southeast Asia Guillain-Barré Syndrome Market Size by Application

    10 India

    • 10.1 India Guillain-Barré Syndrome Market Size (2014-2019)
    • 10.2 Guillain-Barré Syndrome Key Players in India
    • 10.3 India Guillain-Barré Syndrome Market Size by Type
    • 10.4 India Guillain-Barré Syndrome Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Guillain-Barré Syndrome Market Size (2014-2019)
    • 11.2 Guillain-Barré Syndrome Key Players in Central & South America
    • 11.3 Central & South America Guillain-Barré Syndrome Market Size by Type
    • 11.4 Central & South America Guillain-Barré Syndrome Market Size by Application

    12 International Players Profiles

    • 12.1 Grifols
      • 12.1.1 Grifols Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Guillain-Barré Syndrome Introduction
      • 12.1.4 Grifols Revenue in Guillain-Barré Syndrome Business (2014-2019)
      • 12.1.5 Grifols Recent Development
    • 12.2 CSL Behring
      • 12.2.1 CSL Behring Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Guillain-Barré Syndrome Introduction
      • 12.2.4 CSL Behring Revenue in Guillain-Barré Syndrome Business (2014-2019)
      • 12.2.5 CSL Behring Recent Development
    • 12.3 Octapharma
      • 12.3.1 Octapharma Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Guillain-Barré Syndrome Introduction
      • 12.3.4 Octapharma Revenue in Guillain-Barré Syndrome Business (2014-2019)
      • 12.3.5 Octapharma Recent Development
    • 12.4 Nihon Pharmaceutical
      • 12.4.1 Nihon Pharmaceutical Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Guillain-Barré Syndrome Introduction
      • 12.4.4 Nihon Pharmaceutical Revenue in Guillain-Barré Syndrome Business (2014-2019)
      • 12.4.5 Nihon Pharmaceutical Recent Development
    • 12.5 Akari Therapeutics
      • 12.5.1 Akari Therapeutics Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Guillain-Barré Syndrome Introduction
      • 12.5.4 Akari Therapeutics Revenue in Guillain-Barré Syndrome Business (2014-2019)
      • 12.5.5 Akari Therapeutics Recent Development
    • 12.6 China Biologic Products Holdings
      • 12.6.1 China Biologic Products Holdings Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Guillain-Barré Syndrome Introduction
      • 12.6.4 China Biologic Products Holdings Revenue in Guillain-Barré Syndrome Business (2014-2019)
      • 12.6.5 China Biologic Products Holdings Recent Development
    • 12.7 Biotest
      • 12.7.1 Biotest Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Guillain-Barré Syndrome Introduction
      • 12.7.4 Biotest Revenue in Guillain-Barré Syndrome Business (2014-2019)
      • 12.7.5 Biotest Recent Development
    • 12.8 Kedrion
      • 12.8.1 Kedrion Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Guillain-Barré Syndrome Introduction
      • 12.8.4 Kedrion Revenue in Guillain-Barré Syndrome Business (2014-2019)
      • 12.8.5 Kedrion Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Guillain-Barré Syndrome is a rapid-onset muscle weakness caused by the immune system damaging the peripheral nervous system.
      In 2018, the global Guillain-Barré Syndrome market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Guillain-Barré Syndrome status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Guillain-Barré Syndrome development in United States, Europe and China.

      The key players covered in this study
      Grifols
      CSL Behring
      Octapharma
      Nihon Pharmaceutical
      Akari Therapeutics
      China Biologic Products Holdings
      Biotest
      Kedrion

      Market segment by Type, the product can be split into
      Intravenous Immunoglobulin
      Plasma Exchange
      Analgesics
      Anticonvulsants
      LMWH

      Market segment by Application, split into
      Hospital Pharmacies
      Retail Pharmacies
      Home Care
      Clinics

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Guillain-Barré Syndrome status, future forecast, growth opportunity, key market and key players.
      To present the Guillain-Barré Syndrome development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Guillain-Barré Syndrome are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now